BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7379059)

  • 1. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE; Straus MJ
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release.
    Tomita K; Plager JE
    Cancer Res; 1979 Nov; 39(11):4407-11. PubMed ID: 498073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
    Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
    Alate AD; Khandalekar DD; Amonkar AJ; Adwankar MK; Sahasrabudhe MB
    Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pulse and continuous intravenous infusion of cis-diamminedichloroplatinum on L1210 leukemia in vivo.
    Moran RE; Straus MJ
    Cancer Res; 1981 Dec; 41(12 Pt 1):4993-6. PubMed ID: 7198009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
    Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
    Bergeron RJ; Ingeno MJ
    Cancer Res; 1987 Nov; 47(22):6010-6. PubMed ID: 3664504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle synchronization of the mouse S-180 tumor following alternating period of hydroxyurea-blockade and release.
    Tomita K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Nov; 53(11):1687-95. PubMed ID: 528803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
    Prakash NJ; Sunkara PS
    Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia.
    Smets LA; Bout B; Brouwer M; Tulp A
    J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
    Shimizu T
    Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.